Copyright
©The Author(s) 2023.
World J Transplant. Sep 18, 2023; 13(5): 276-289
Published online Sep 18, 2023. doi: 10.5500/wjt.v13.i5.276
Published online Sep 18, 2023. doi: 10.5500/wjt.v13.i5.276
Table 1 Definitions of terms used to describe the living donors at different stages of kidney donation including access, counseling, evaluation, acceptance, candidacy, and donation with kidney transplantation of related intended patients
| Term | Definition |
| PLD | An individual who confirmed his willingness to donate a kidney to an intended patient at the initial counseling settings and was ready to start the evaluation for kidney donation, regardless of the commencement of the evaluation |
| Related PLD | PLD who had a relative intended patient with end-stage renal disease up to the 4th degree of genetic relatedness. Regardless of their genetic relatedness, the wife or husband of a recipient was considered a related PLD |
| Excluded PLD | PLD who was disqualified as a kidney donor and excluded from the process of kidney donation by KT team due to causes that disqualify candidacy to donate a kidney, such as medical, immunological, or financial causes |
| Regressed PLD | PLD who withdrew his decision of kidney donation at any stage after an initial confirmation of the donation decision and before the operation |
| Released PLD1 | PLD who was still willing and completed or was still continuing the evaluation, but the related intended patient was withdrawn from KT preparation due to any cause |
| Candidate PLD | PLD who completed all the steps of evaluation and was finally accepted by the KT team for kidney donation, regardless of the later regression or release from donation |
| Accepted PLD | PLD who completed the evaluation without exclusion from kidney donation and was accepted for donation without release or regression from his willingness |
| LD | PLD becomes a LD when he succeeds in donating a kidney to his/her intended patient, which also means KT was achieved |
| Relatedness degrees and forms2 | First degree: father, mother, son, daughter, wife, and husband. Second degree: brother, sister, grandfather, grandmother, grandson, and granddaughter. Third degree: nephew, uncle and aunt. Fourth degree: cousins |
Table 2 Demographic and clinical characteristics of patients and related potential living donors presented as total patients (n = 212) and as a comparison between patients with candidate (n = 74) and patients with non-candidate (n = 138) potential living donors
| Characteristics | Total patients, n = 212 | Patients with candidate PLDs, n = 74 | Patients with non-candidate PLDs, n = 138 | P value |
| mean ± SD (range)/number (%) | ||||
| Mean age in yr | 31.2 ± 10.6 (13-66) | 29.1 ± 9.6 (13-57) | 32.9 ± 12.0 (14-66) | 0.041 |
| Sex, n = 212 | ||||
| Males | 173 (81.6%) | 67 (90.5%) | 106 (76.8%) | 0.087 |
| Females | 39 (18.4%) | 7 (9.5%) | 32 (23.2%) | |
| Status of dialysis at presentation, n = 212 | ||||
| Preemptive | 19 (9.0%) | 5 (6.8%) | 14 (10.1%) | 0.462 |
| On regular hemodialysis | 193 (91.0%) | 69 (93.2%) | 124 (89.9%) | |
| Primary kidney disease, n = 212 | ||||
| Unknown | 167 (78.8%) | 56 (75.7%) | 111 (80.4%) | 0.088 |
| Systemic disease | 14 (6.6%) | 3 (2.7%) | 11 (8.0%) | |
| Glomerulonephritis | 6 (2.8%) | 3 (4.0%) | 3 (2.2%) | |
| Hereditary renal disease | 5 (3.8%) | 2 (2.7%) | 3 (2.2%) | |
| Obstructive uropathy | 11 (5.2%) | 8 (10.8%) | 3 (2.2%) | |
| Urolithiasis | 9 (4.2%) | 2 (2.7%) | 7 (5.1%) | |
| Categories of primary kidney disease, n = 212 | ||||
| Unknown | 167 (78.8%) | 56 (75.7%) | 111 (80.4%) | 0.154 |
| Systemic disease | 14 (6.6%) | 3 (4.0%) | 11 (8.0%) | |
| Local, renal/urinary | 31 (14.6%) | 15 (20.3%) | 16 (11.6%) | |
| Patients per number of PLDs, n = 212 | ||||
| Patients with one PLD | 165 (77.8%) | 53 (71.6%) | 112 (81.2%) | 0.265 |
| Patients with two PLDs | 39 (18.4%) | 17 (23.0%) | 22 (15.9%) | |
| Patients with three PLDs | 8 (3.8%) | 4 (5.4%) | 4 (2.9%) | |
Table 3 Patient characteristics distributed per extent and outcome of evaluation of their potential living donors presented as total patients (n = 212) and as a comparison between patients with candidate (n = 74) and patients with non-candidate (n = 138) potential living donors.
| Characteristics | Total patients, n = 212 | Patients with candidate PLDs, n = 74 | Patients with non-candidate PLDs, n = 138 | P value |
| mean ± SD (range)/number (%) | ||||
| Patients per extent of evaluation of their PLDs1, n = 212 | ||||
| Completed 1 | 71 (33.5%) | 54 (73%) | 17 (12.3%) | < 0.001 |
| Completed 1/incomplete 1 | 15 (7.1%) | 7 (9.5%) | 8 (5.8%) | |
| Completed 1/incomplete 2 | 2 (0.9%) | 2 (2.7%) | 0 (0%) | |
| Completed 1/not evaluated 1 | 7 (3.3%) | 6 (8.1%) | 1 (0.7%) | |
| Completed 2 | 3 (1.4%) | 3 (4.1%) | 0 (0%) | |
| Completed 2/incomplete 1 | 1 (0.5%) | 0 (0%) | 1 (0.7%) | |
| Completed 3 | 2 (0.9%) | 2 (2.7%) | 0 (0%) | |
| Incomplete 1 | 94 (44.3%) | 0 (0%) | 94 (68.1%) | |
| Incomplete 1/not evaluated 1 | 1 (0.5%) | 0 (0%) | 1 (0.7%) | |
| Incomplete 1/not evaluated 2 | 1 (0.5%) | 0 (0%) | 1 (0.7%) | |
| Incomplete 2 | 13 (6.1%) | 0 (0%) | 13 (9.4%) | |
| Incomplete 3 | 2 (0.9%) | 0 (0%) | 2 (1.5%) | |
| Patients per acceptance of their PLDs1, n = 212 | ||||
| Accepted 1 | 44 (20.6%) | 44 (59.5%) | 0 (0%) | < 0.001 |
| Accepted 1/excluded 1 | 8 (3.8%) | 8 (10.8%) | 0 (0%) | |
| Accepted 1/excluded 2 | 2 (0.9%) | 2 (2.7%) | 0 (0%) | |
| Accepted 1/not evaluated 1 | 4 (1.9%) | 4 (5.4%) | 0 (0%) | |
| Excluded 1 | 81 (38.2%) | 0 (0%) | 81 (0%) | |
| Excluded 2 | 14 (6.6%) | 0 (0%) | 14 (10.1%) | |
| Excluded 3 | 2 (0.9%) | 0 (0%) | 2 (1.5%) | |
| Excluded 1/released 1 | 5 (2.4%) | 1 (1.4%) | 4 (2.9%) | |
| Excluded 1/regressed 1 | 3 (1.4%) | 1 (1.4%) | 2 (1.5%) | |
| Excluded 1/not evaluated 1 | 2 (0.9%) | 0 (0%) | 2 (1.5%) | |
| Excluded 1/not evaluated 2 | 1 (0.5%) | 0 (0%) | 1 (0.7%) | |
| Excluded 2/released 1 | 2 (0.9%) | 1 (1.4%) | 1 (0.7%) | |
| Excluded 2/regressed 1 | 1 (0.5%) | 1 (1.4%) | 0 (0%) | |
| Released 1 | 28 (13.2%) | 7 (9.5%) | 21 (15.2%) | |
| Released 1/not evaluated 1 | 2 (0.9%) | 2 (2.7%) | 0 (0%) | |
| Regressed 1 | 12 (5.7%) | 3 (4.1%) | 9 (6.5%) | |
| Regressed 2 | 1 (0.5%) | 0 (0%) | 1 (0.7%) | |
Table 4 Patients distributed per characteristics of exclusion of their potential living donors presented as total patients (n = 212) and as a comparison between patients with candidate (n = 74) and patients with non-candidate (n = 138) potential living donors.
| Characteristics | Total patients, n = 212 | Patients with candidate PLDs, n = 74 | Patients with non-candidate PLDs, n = 138 | P value |
| mean ± SD (range)/number (%) | ||||
| Patients per number of excluded PLDs, n = 121 | ||||
| Patients with one excluded PLD | 100 (82.6%) | 10 (71.4%) | 90 (84.1%) | 0.764 |
| Patients with two excluded PLDs | 19 (15.7%) | 4 (28.6%) | 15 (14.0%) | |
| Patients with three excluded PLDs | 2 (1.7%) | 0 (0%) | 2 (1.9%) | |
| Patients per causes of exclusion of their PLDs, n = 1211 | ||||
| Combined immunological and medical causes | 14 (11.6%) | 3 (21.4%) | 11 (10.3%) | 0.680 |
| HLA-incompatibility | 24 (19.8%) | 3 (21.4%) | 21 (19.6%) | |
| ABO-incompatibility | 20 (16.5%) | 1 (7.1%) | 19 (17.8%) | |
| ABO and HLA-incompatibility | 2 (1.7%) | 0 (0%) | 2 (1.9%) | |
| Age | 8 (6.6%) | 0 (0%) | 8 (7.5%) | |
| Diabetes mellitus | 4 (3.3%) | 0 (0%) | 4 (3.7%) | |
| HCV positive | 5 (4.1%) | 2 (14.3%) | 3 (2.8%) | |
| Hypertension | 11 (9.1%) | 4 (28.6%) | 7 (6.5%) | |
| Leprosy | 1 (0.8%) | 0 (0%) | 1 (0.9%) | |
| Low GFR | 4 (3.3%) | 1 (7.1%) | 3 (2.8%) | |
| High potential recurrence of primary kidney disease | 6 (5.0%) | 0 (0%) | 6 (5.6%) | |
| Proteinuria | 12 (9.9%) | 0 (0%) | 12 (11.2%) | |
| Psoriasis | 1 (0.8%) | 0 (0%) | 1 (0.9%) | |
| Rheumatoid arthritis | 1 (0.8%) | 0 (0%) | 1 (0.9%) | |
| Urolithiasis | 5 (4.1%) | 0 (0%) | 5 (4.7%) | |
| Financial causes | 3 (2.5%) | 0 (0%) | 3 (2.8%) | |
| Patients per main category of causes of exclusion of their PLDs, n = 121 | ||||
| Combined immunological and medical causes | 14 (11.6%) | 3 (21.4%) | 11 (10.3%) | 0.866 |
| Immunologic mismatches | 46 (38%) | 4 (28.6%) | 42 (39.3%) | |
| Medical causes | 58 (47.9%) | 7 (50.0%) | 51 (47.7%) | |
| Financial causes | 3 (2.5%) | 0 (0%) | 3 (2.8%) | |
| Patients per timing of PLDs regression, n = 18 | ||||
| During evaluation | 13 (72.2%) | 0 (0%) | 13 (100.0%) | NA |
| After evaluation | 5 (27.8%) | 5 (100.0%) | 0 (0%) | |
| Patients per cause of release of PLDs, n = 37 | ||||
| Patient death | 4 (10.8%) | 3 (27.3%) | 1 (3.9%) | 0.186 |
| Patient regression | 22 (59.5%) | 6 (54.5%) | 16 (61.5%) | |
| Patient non-candidacy | 11 (29.7%) | 2 (18.2%) | 9 (34.6%) | |
| Patients per timing of release of PLDs, n = 37 | ||||
| During evaluation | 26 (70.3%) | 0 (0%) | 26 (100.0%) | NA |
| After evaluation | 11 (29.7%) | 11 (100.0%) | 0 (0%) | |
| Fate of patients with evaluated PLDs, n = 212 | ||||
| Transplantation in our center | 58 (27.4%) | 58 (78.4%) | 0 (0%) | NA |
| Transplantation in another center | 14 (6.6%) | 1 (1.4%) | 13 (9.4%) | 0.024 |
| On hemodialysis | 122 (57.6%) | 12 (16.2%) | 110 (79.7%) | < 0.001 |
| Death | 9 (4.2%) | 3 (4.1%) | 6 (4.4%) | 0.920 |
| Unknown | 9 (4.2%) | 0 (0%) | 9 (6.5%) | 0.024 |
Table 5 Characteristics of potential living donors presented as total (n = 257) and as a comparison between the candidate (n = 74) and non-candidate (n = 183) groups of donors
| Characteristics | Total PLDs, n = 257 | Candidate PLDs, n = 74 | Non-candidate PLDs, n = 183 | P value |
| mean ± SD (range)/number (%) | ||||
| Mean age in yr | 40.5 ± 10.4 (18-65) | 41.0 ± 10.5 (21-60) | 40.4 ± 10.5 (18-65) | 0.498 |
| Sex | ||||
| Female | 169 (65.8%) | 49 (66.2%) | 120 (65.6%) | > 0.999 |
| Male | 88 (34.2%) | 25 (33.8%) | 63 (34.4%) | |
| Form of relatedness1 | ||||
| Aunt | 4 (1.6%) | 4 (5.4%) | 0 (0%) | 0.286 |
| Brother | 51 (19.8%) | 14 (18.9%) | 37 (20.2%) | |
| Cousin | 4 (1.6%) | 0 (0%) | 4 (2.2%) | |
| Daughter | 4 (1.6%) | 1 (1.4%) | 3 (1.6%) | |
| Father | 23 (8.9%) | 7 (9.5%) | 16 (8.7%) | |
| Husband | 6 (2.3%) | 2 (2.7%) | 4 (2.2%) | |
| Mother | 76 (29.6%) | 23 (31.1%) | 53 (29%) | |
| Nephew | 1 (0.4%) | 0 (0%) | 1 (0.6%) | |
| Sister | 53 (20.6%) | 13 (17.6%) | 40 (21.9%) | |
| Son | 4 (1.6%) | 1 (1.4%) | 3 (1.6%) | |
| Uncle | 1 (0.4%) | 1 (1.4%) | 0 (0%) | |
| Wife | 30 (11.7%) | 8 (10.8%) | 22 (12.0%) | |
| Degree of relatedness | ||||
| First | 143 (55.6%) | 42 (56.8%) | 101 (55.2%) | 0.020 |
| Second | 104 (40.5%) | 27 (36.5%) | 77 (42.1%) | |
| Third | 6 (2.3%) | 5 (6.8%) | 1 (0.6%) | |
| Fourth | 4 (1.6%) | 0 (0%) | 4 (2.2%) | |
| Extent of evaluation | ||||
| Complete | 109 (42.4%) | 74 (100.0%) | 35 (19.1%) | NA |
| Incomplete | 148 (57.6%) | 0 (0%) | 148 (80.9%) | |
| Fate of PLDs | ||||
| Donated | 58 (22.6%) | 58 (78.4%) | 0 (0%) | NA |
| Excluded | 144 (56.0%) | 0 (0%) | 144 (78.7%) | NA |
| Regressed2 | 18 (7.0%) | 5 (6.8%) | 13 (31.6%) | |
| During evaluation | 13 (72.2%) | 0 (0%) | 13 (100.0%) | NA |
| After evaluation | 5 (27.8%) | 5 (100%) | 0 (0%) | |
| Released | 37 (14.4%) | 11 (14.9%) | 26 (68.4%) | |
| Causes of donor release | ||||
| Patient death | 4 (10.8%) | 3 (27.3%) | 1 (3.9%) | 0.186 |
| Patient regression | 22 (59.5%) | 6 (54.5%) | 16 (61.5%) | |
| Patient non-candidacy | 11 (29.7%) | 2 (18.2%) | 9 (34.6%) | |
| Timing of PLDs release | ||||
| During evaluation | 26 (70.3%) | 0 (0%) | 26 (100.0%) | NA |
| After evaluation | 11 (29.7%) | 11 (100.0%) | 0 (0%) | |
| Time spent in PLDs evaluation in mo | 2.2 ± 1.5 (0.5-6.0) | 4.0 ± 0.9 (1-6) | 1.5 ± 1.2 (0.5-5.0) | < 0.001 |
Table 6 Multivariate logistic regression of the potential variables influencing the candidacy of potential living donors with a completed preparation
| Variables | Modality | Odds ratio | P value |
| Dialysis status | Preemptive vs on dialysis | 0.66 (0.23-1.94) | 0.451 |
| Number of potential donors | Single vs multiple | 1.69 (0.87-3.28) | 0.123 |
| Donor age | Increasing age | 1.0 (0.97-1.03) | 0.925 |
| Donor sex | Men vs women | 1.02 (0.55-1.92) | 0.940 |
| Relatedness degree | First vs more than first | 1.07 (0.55-2.1) | 0.834 |
- Citation: Gadelkareem RA, Abdelgawad AM, Mohammed N, Reda A, Azoz NM, Zarzour MA, Hammouda HM, Khalil M. Reasons and effects of the decline of willing related potential living kidney donors. World J Transplant 2023; 13(5): 276-289
- URL: https://www.wjgnet.com/2220-3230/full/v13/i5/276.htm
- DOI: https://dx.doi.org/10.5500/wjt.v13.i5.276
